Aptamer partners with Hong Kong biotech to develop targeted gene therapies 31-Jan-2023 By Jane Byrne UK based, Aptamer Group, and Hong Kong headquartered, BaseCure Therapeutics, are paring up on the development of Optimer-targeted gene therapies.
Novartis looks to manufacturing investment to drive down cost of siRNA drug 09-Aug-2021 By Nick Taylor Novartis has outlined plans to drive down the cost of producing its siRNA therapy, Leqvio, to support use in larger patient populations.
